Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.4 to v3.6.5, indicating a minor platform update. There is no indication that study content, eligibility criteria, or results text has changed.
    Difference
    0.1%
    Check dated 2026-08-08T19:02:34.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, representing a minor update to the page metadata. This change does not affect the study details, endpoints, or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:28.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows a newer revision line (v3.6.3) for the study documents, replacing the previous v3.6.2. This reflects an updated protocol/SAP version in the documents section.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:48.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, replacing v3.6.0 with v3.6.2, reflecting a newer deployment of the page system. This change does not modify study content or related data.
    Difference
    0.1%
    Check dated 2026-06-27T00:12:26.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    New user-help sections were added, and the page revision and verification status indicators were updated to reflect current study details.
    Difference
    2%
    Check dated 2026-06-12T16:48:07.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, signaling a minor update to the ClinicalTrials.gov record's content/metadata.
    Difference
    0.1%
    Check dated 2026-06-05T12:09:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.